| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ERCC6 MYO1D MYO10 SPO11 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 MSH6 MYO1F HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 5.17e-07 | 614 | 192 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.12e-06 | 36 | 192 | 6 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.12e-06 | 36 | 192 | 6 | GO:0015662 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.59e-06 | 11 | 192 | 4 | GO:0005388 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC6 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 6.01e-06 | 441 | 192 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1D IQGAP2 MYO10 IQGAP1 SCN3A IQGAP3 MYO1F ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.47e-05 | 230 | 192 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.87e-05 | 62 | 192 | 6 | GO:0019829 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 8.88e-05 | 109 | 192 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | GMP 5'-nucleotidase activity | 9.20e-05 | 2 | 192 | 2 | GO:0050484 | |
| GeneOntologyMolecularFunction | sodium ion binding | 2.95e-04 | 14 | 192 | 3 | GO:0031402 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ERCC6 RGS9 RHOBTB1 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 5.10e-04 | 775 | 192 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | IMP 5'-nucleotidase activity | 5.45e-04 | 4 | 192 | 2 | GO:0050483 | |
| GeneOntologyMolecularFunction | actin binding | MYO1D IQGAP2 MYO10 IQGAP1 DST SYNE2 DIAPH1 DMD IQGAP3 OPHN1 LRPPRC FRG1 MYO1F | 7.73e-04 | 479 | 192 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 9.02e-04 | 5 | 192 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 9.02e-04 | 5 | 192 | 2 | GO:0004994 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.25e-03 | 49 | 192 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ERCC6 RGS9 RHOBTB1 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 1.26e-03 | 839 | 192 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ERCC6 RGS9 RHOBTB1 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 1.28e-03 | 840 | 192 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ERCC6 RGS9 RHOBTB1 HFM1 KIF22 HSP90AB1 HSP90AB3P ABCB5 SMC2 HSP90AB2P ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 1.28e-03 | 840 | 192 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | actin filament binding | 1.63e-03 | 227 | 192 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.68e-03 | 53 | 192 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.71e-03 | 178 | 192 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | MutLalpha complex binding | 1.87e-03 | 7 | 192 | 2 | GO:0032405 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.87e-03 | 7 | 192 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 1.93e-03 | 26 | 192 | 3 | GO:0031420 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 7.82e-07 | 3 | 191 | 3 | GO:1902407 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 7.82e-07 | 3 | 191 | 3 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 7.82e-07 | 3 | 191 | 3 | GO:1903479 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 3.11e-06 | 4 | 191 | 3 | GO:2000689 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | TRIM24 DMXL1 AGTR1 DIAPH1 CCR7 DMD CA4 NT5E ANXA6 CAPN3 TASL SLC9C2 TNFSF11 THY1 ATP1A1 ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 9.29e-06 | 705 | 191 | 20 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | TRIM24 DMXL1 AGTR1 DIAPH1 CCR7 DMD CA4 NT5E ANXA6 CAPN3 TASL SLC9C2 TNFSF11 THY1 ATP1A1 ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.19e-05 | 717 | 191 | 20 | GO:0050801 |
| GeneOntologyBiologicalProcess | cardiac conduction | 4.05e-05 | 100 | 191 | 7 | GO:0061337 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly | 6.30e-05 | 9 | 191 | 3 | GO:0000915 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in cytokinesis | 6.30e-05 | 9 | 191 | 3 | GO:0000912 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | TRIM24 DIAPH1 CCR7 DMD NT5E ANXA6 CAPN3 TNFSF11 THY1 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 7.23e-05 | 389 | 191 | 13 | GO:0055074 |
| GeneOntologyBiologicalProcess | negative regulation of platelet-derived growth factor receptor-alpha signaling pathway | 8.53e-05 | 2 | 191 | 2 | GO:2000584 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring organization | 8.94e-05 | 10 | 191 | 3 | GO:0044837 | |
| GeneOntologyBiologicalProcess | regulation of cardiac conduction | 1.41e-04 | 29 | 191 | 4 | GO:1903779 | |
| GeneOntologyBiologicalProcess | metal ion transport | RGS9 CD84 KCNU1 MAGED2 SCN3A AGTR1 DIAPH1 CCR7 DMD ANXA6 CAPN3 FLVCR2 SLC9C2 OPRM1 THY1 KCNT2 ATP1A1 ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 1.52e-04 | 1000 | 191 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.62e-04 | 12 | 191 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 2.02e-04 | 91 | 191 | 6 | GO:0140115 | |
| GeneOntologyCellularComponent | cell leading edge | MYO1D IQGAP2 MYO10 PECAM1 ADGRV1 IQGAP1 DST PTPRJ SYNE2 DIAPH1 FGD5 DMD USH2A OPRM1 THY1 ATP2B1 ATP2B2 | 3.19e-06 | 500 | 189 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | leading edge membrane | MYO1D ADGRV1 PTPRJ SYNE2 DIAPH1 FGD5 USH2A OPRM1 THY1 ATP2B1 ATP2B2 | 3.48e-06 | 210 | 189 | 11 | GO:0031256 |
| GeneOntologyCellularComponent | cell projection membrane | MYO1D MYO10 ADGRV1 PTPRJ SYNE2 DIAPH1 FGD5 DMD USH2A CA4 HSP90AB1 OPRM1 THY1 ATP2B1 ATP2B2 | 9.38e-06 | 431 | 189 | 15 | GO:0031253 |
| GeneOntologyCellularComponent | neuron projection membrane | 9.48e-06 | 82 | 189 | 7 | GO:0032589 | |
| GeneOntologyCellularComponent | sarcolemma | 6.01e-05 | 190 | 189 | 9 | GO:0042383 | |
| GeneOntologyCellularComponent | basal part of cell | MYO1D IQGAP1 DST MPP4 AGTR1 CA4 HSP90AB1 SLCO1B7 ATP1A1 ATP2B1 ATP2B2 ATP2B4 | 1.77e-04 | 378 | 189 | 12 | GO:0045178 |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.22e-04 | 290 | 189 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | basal plasma membrane | MYO1D IQGAP1 DST AGTR1 CA4 HSP90AB1 SLCO1B7 ATP1A1 ATP2B1 ATP2B2 ATP2B4 | 3.95e-04 | 354 | 189 | 11 | GO:0009925 |
| GeneOntologyCellularComponent | sarcomere | 4.55e-04 | 249 | 189 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 4.82e-04 | 4 | 189 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | USH2 complex | 4.82e-04 | 4 | 189 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | RNA polymerase III complex | 5.37e-04 | 18 | 189 | 3 | GO:0005666 | |
| GeneOntologyCellularComponent | sarcoplasm | 6.00e-04 | 114 | 189 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 6.06e-04 | 43 | 189 | 4 | GO:0032809 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | MYO1D IQGAP1 AGTR1 CA4 HSP90AB1 SLCO1B7 ATP1A1 ATP2B1 ATP2B2 ATP2B4 | 6.93e-04 | 320 | 189 | 10 | GO:0016323 |
| GeneOntologyCellularComponent | CKM complex | 7.99e-04 | 5 | 189 | 2 | GO:1990508 | |
| GeneOntologyCellularComponent | cell body membrane | 8.52e-04 | 47 | 189 | 4 | GO:0044298 | |
| GeneOntologyCellularComponent | filopodium membrane | 8.58e-04 | 21 | 189 | 3 | GO:0031527 | |
| GeneOntologyCellularComponent | myofibril | 8.78e-04 | 273 | 189 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.19e-03 | 6 | 189 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.19e-03 | 6 | 189 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.19e-03 | 6 | 189 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.19e-03 | 6 | 189 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | axon | MYO1D MYCBP2 IQGAP1 DST SACS MPP4 SCN3A DMD USH2A HSP90AB1 EXOC6 OPHN1 OPRM1 WDR47 THY1 ATP1A1 ATP1A3 ATP2B3 | 1.24e-03 | 891 | 189 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.35e-03 | 90 | 189 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ERCC6 ATR NOC2L SMNDC1 CDK19 NUP205 SYNE2 MED12L AFF1 ANAPC7 MED12 HSP90AB1 MMS22L ARID4A SAP30L POLR3A POLR3F MSH6 POLR3B RNF2 DPF3 FRG1 DDX21 CPSF3 | 1.53e-03 | 1377 | 189 | 24 | GO:0140513 |
| GeneOntologyCellularComponent | dendrite membrane | 1.65e-03 | 56 | 189 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.20e-03 | 8 | 189 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | B-WICH complex | 2.20e-03 | 8 | 189 | 2 | GO:0110016 | |
| GeneOntologyCellularComponent | supramolecular fiber | KNTC1 IQGAP2 PECAM1 CMYA5 MEF2C IQGAP1 DST SYNE2 DIAPH1 DMD KRT25 LMNTD1 KIF22 CAPN3 WDR47 LRPPRC FRG1 MYO1F MYOM2 ATP2B4 DNAH11 | 2.34e-03 | 1179 | 189 | 21 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KNTC1 IQGAP2 PECAM1 CMYA5 MEF2C IQGAP1 DST SYNE2 DIAPH1 DMD KRT25 LMNTD1 KIF22 CAPN3 WDR47 LRPPRC FRG1 MYO1F MYOM2 ATP2B4 DNAH11 | 2.54e-03 | 1187 | 189 | 21 | GO:0099081 |
| GeneOntologyCellularComponent | Z disc | 2.55e-03 | 151 | 189 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.81e-03 | 277 | 189 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.83e-03 | 164 | 189 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | actin-based cell projection | 3.89e-03 | 278 | 189 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | I band | 4.06e-03 | 166 | 189 | 6 | GO:0031674 | |
| Domain | ATPase_P-typ_TM_dom | 7.07e-09 | 16 | 188 | 6 | IPR023298 | |
| Domain | - | 7.07e-09 | 16 | 188 | 6 | 1.20.1110.10 | |
| Domain | ATP_Ca_trans_C | 9.94e-09 | 4 | 188 | 4 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 9.94e-09 | 4 | 188 | 4 | PF12424 | |
| Domain | P-type_ATPase_IIB | 9.94e-09 | 4 | 188 | 4 | IPR006408 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.08e-08 | 17 | 188 | 6 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.08e-08 | 17 | 188 | 6 | PF00689 | |
| Domain | Cation_ATPase_N | 1.61e-08 | 18 | 188 | 6 | PF00690 | |
| Domain | Cation_ATPase_N | 1.61e-08 | 18 | 188 | 6 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 2.34e-08 | 19 | 188 | 6 | IPR004014 | |
| Domain | RasGAP_C | 1.00e-06 | 3 | 188 | 3 | IPR000593 | |
| Domain | RasGAP_C | 1.00e-06 | 3 | 188 | 3 | PF03836 | |
| Domain | ATPase_P-typ_cyto_domN | 1.22e-06 | 35 | 188 | 6 | IPR023299 | |
| Domain | HAD-like_dom | 1.29e-06 | 79 | 188 | 8 | IPR023214 | |
| Domain | ATPase_P-typ_P_site | 1.46e-06 | 36 | 188 | 6 | IPR018303 | |
| Domain | P_typ_ATPase | 1.46e-06 | 36 | 188 | 6 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.46e-06 | 36 | 188 | 6 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.72e-06 | 37 | 188 | 6 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.72e-06 | 37 | 188 | 6 | PF00122 | |
| Domain | HJURP_C | 3.99e-06 | 4 | 188 | 3 | IPR022102 | |
| Domain | MADS_MEF2-like | 3.99e-06 | 4 | 188 | 3 | IPR033896 | |
| Domain | HJURP_C | 3.99e-06 | 4 | 188 | 3 | PF12347 | |
| Domain | CH | 6.57e-06 | 70 | 188 | 7 | PF00307 | |
| Domain | IQ | 7.23e-06 | 71 | 188 | 7 | PF00612 | |
| Domain | - | 7.23e-06 | 71 | 188 | 7 | 1.10.418.10 | |
| Domain | CH | 8.71e-06 | 73 | 188 | 7 | PS50021 | |
| Domain | CH-domain | 1.04e-05 | 75 | 188 | 7 | IPR001715 | |
| Domain | IQ | 1.74e-05 | 81 | 188 | 7 | SM00015 | |
| Domain | MADS_BOX_1 | 1.96e-05 | 6 | 188 | 3 | PS00350 | |
| Domain | MADS | 1.96e-05 | 6 | 188 | 3 | SM00432 | |
| Domain | SRF-TF | 1.96e-05 | 6 | 188 | 3 | PF00319 | |
| Domain | MADS_BOX_2 | 1.96e-05 | 6 | 188 | 3 | PS50066 | |
| Domain | TF_MADSbox | 3.41e-05 | 7 | 188 | 3 | IPR002100 | |
| Domain | IQ_motif_EF-hand-BS | 3.46e-05 | 90 | 188 | 7 | IPR000048 | |
| Domain | IQ | 4.28e-05 | 93 | 188 | 7 | PS50096 | |
| Domain | CH | 4.84e-05 | 65 | 188 | 6 | SM00033 | |
| Domain | HATC_C_dom | 5.42e-05 | 8 | 188 | 3 | IPR008906 | |
| Domain | Dimer_Tnp_hAT | 5.42e-05 | 8 | 188 | 3 | PF05699 | |
| Domain | Factor_5/8 | 1.01e-04 | 2 | 188 | 2 | IPR024715 | |
| Domain | Med12 | 1.01e-04 | 2 | 188 | 2 | PF09497 | |
| Domain | Mediator_Med12_catenin-bd | 1.01e-04 | 2 | 188 | 2 | IPR021989 | |
| Domain | Med12-PQL | 1.01e-04 | 2 | 188 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 1.01e-04 | 2 | 188 | 2 | PF12145 | |
| Domain | Med12 | 1.01e-04 | 2 | 188 | 2 | SM01281 | |
| Domain | Mediator_Med12 | 1.01e-04 | 2 | 188 | 2 | IPR019035 | |
| Domain | Mediator_Med12_LCEWAV | 1.01e-04 | 2 | 188 | 2 | IPR021990 | |
| Domain | ATP2B1/4 | 1.01e-04 | 2 | 188 | 2 | IPR030319 | |
| Domain | - | 2.87e-04 | 32 | 188 | 4 | 3.40.1110.10 | |
| Domain | - | 2.87e-04 | 32 | 188 | 4 | 2.70.150.10 | |
| Domain | ZnF_TTF | 3.00e-04 | 3 | 188 | 2 | SM00597 | |
| Domain | Znf_TTF | 3.00e-04 | 3 | 188 | 2 | IPR006580 | |
| Domain | RasGAP | 3.37e-04 | 14 | 188 | 3 | SM00323 | |
| Domain | RasGAP_CS | 3.37e-04 | 14 | 188 | 3 | IPR023152 | |
| Domain | RasGAP | 4.18e-04 | 15 | 188 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 4.18e-04 | 15 | 188 | 3 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 4.18e-04 | 15 | 188 | 3 | PS50018 | |
| Domain | - | 5.10e-04 | 16 | 188 | 3 | 1.10.506.10 | |
| Domain | BK_channel_a | 5.97e-04 | 4 | 188 | 2 | PF03493 | |
| Domain | K_chnl_Ca-activ_BK_asu | 5.97e-04 | 4 | 188 | 2 | IPR003929 | |
| Domain | RasGAP_dom | 7.33e-04 | 18 | 188 | 3 | IPR001936 | |
| Domain | Somatstn_rcpt | 9.88e-04 | 5 | 188 | 2 | IPR000586 | |
| Domain | PHR | 9.88e-04 | 5 | 188 | 2 | IPR012983 | |
| Domain | GATASE_TYPE_2 | 9.88e-04 | 5 | 188 | 2 | PS51278 | |
| Domain | Cu-oxidase_3 | 9.88e-04 | 5 | 188 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 9.88e-04 | 5 | 188 | 2 | PS00079 | |
| Domain | PHR | 9.88e-04 | 5 | 188 | 2 | PF08005 | |
| Domain | Cu_oxidase_CS | 9.88e-04 | 5 | 188 | 2 | IPR033138 | |
| Domain | DUF4371 | 9.88e-04 | 5 | 188 | 2 | IPR025398 | |
| Domain | DUF4371 | 9.88e-04 | 5 | 188 | 2 | PF14291 | |
| Domain | GATase_2_dom | 9.88e-04 | 5 | 188 | 2 | IPR017932 | |
| Domain | Cu-oxidase_3 | 9.88e-04 | 5 | 188 | 2 | PF07732 | |
| Domain | fn3 | 1.29e-03 | 162 | 188 | 7 | PF00041 | |
| Domain | Cu_oxidase_Cu_BS | 1.47e-03 | 6 | 188 | 2 | IPR002355 | |
| Domain | P-type_ATPase_IIC | 1.47e-03 | 6 | 188 | 2 | IPR005775 | |
| Domain | Spectrin | 1.53e-03 | 23 | 188 | 3 | PF00435 | |
| Domain | ACTININ_2 | 1.53e-03 | 23 | 188 | 3 | PS00020 | |
| Domain | ACTININ_1 | 1.53e-03 | 23 | 188 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.53e-03 | 23 | 188 | 3 | IPR001589 | |
| Domain | AlbA_2 | 2.05e-03 | 7 | 188 | 2 | PF04326 | |
| Domain | Schlafen | 2.05e-03 | 7 | 188 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 2.05e-03 | 7 | 188 | 2 | IPR007421 | |
| Domain | Myosin_TH1 | 2.05e-03 | 7 | 188 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 2.05e-03 | 7 | 188 | 2 | IPR010926 | |
| Domain | TH1 | 2.05e-03 | 7 | 188 | 2 | PS51757 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 2.71e-03 | 8 | 188 | 2 | IPR009011 | |
| Domain | - | IL12B MYCBP2 UNC5B FSTL5 PECAM1 CMYA5 CD84 PTPRJ USH2A SDK2 TRIM42 TGM1 THY1 CRTAM MYOM2 | 2.96e-03 | 663 | 188 | 15 | 2.60.40.10 |
| Domain | Spectrin_repeat | 3.02e-03 | 29 | 188 | 3 | IPR002017 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 4.34e-06 | 12 | 140 | 4 | M27326 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 8.63e-06 | 14 | 140 | 4 | MM15052 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.50e-05 | 54 | 140 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.50e-05 | 54 | 140 | 6 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.67e-05 | 55 | 140 | 6 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 2.06e-05 | 57 | 140 | 6 | MM15643 | |
| Pathway | WP_GPCRS_PEPTIDE | 6.70e-05 | 70 | 140 | 6 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 9.89e-05 | 75 | 140 | 6 | M39696 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.37e-04 | 27 | 140 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 1.59e-04 | 28 | 140 | 4 | M924 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.92e-04 | 203 | 140 | 9 | M5485 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.14e-04 | 130 | 140 | 7 | M27454 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 4.29e-04 | 36 | 140 | 4 | M39831 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.81e-04 | 183 | 140 | 8 | M997 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 5.60e-04 | 103 | 140 | 6 | MM15196 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 ATR MYO1D NOC2L CMYA5 SUCLA2 ME2 GFPT1 IQGAP1 NUP205 MAGED2 DIAPH1 USP7 PUM3 FGD5 ANAPC7 IQGAP3 PCYOX1 HSP90AB1 ANKFY1 NRDC ANXA6 SMC2 POLR3A MSH6 LRPPRC RNF2 SBNO1 ASNS EIF3H ATP1A1 DDX21 ATP2B1 ATP2B3 CPSF3 | 1.71e-13 | 1425 | 195 | 35 | 30948266 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZNF148 VRK3 IQGAP2 NOC2L TRIM24 MEF2A MEF2C MEF2D NUP205 TEX36 XYLT1 PLOD2 ANAPC7 KIF22 HSP90AB1 ARID4A SAP30L SMC2 WDR47 TGM1 RNF2 DDX21 ATP2B1 ATP2B3 | 1.16e-10 | 857 | 195 | 24 | 25609649 |
| Pubmed | KNTC1 MYO1D IQGAP2 NOC2L DGKA IQGAP1 NUP205 DST MAGED2 SACS SYNE2 DMD ANAPC7 HSP90AB1 CTDSPL2 ABCB5 SMC2 MINDY2 LRPPRC RNF2 SBNO1 UGGT2 PHF14 MYOM2 ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 | 6.15e-10 | 1442 | 195 | 30 | 35575683 | |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 9.58e-10 | 4 | 195 | 4 | 12209837 | |
| Pubmed | 9.58e-10 | 4 | 195 | 4 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 9.58e-10 | 4 | 195 | 4 | 8245032 | |
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 9.58e-10 | 4 | 195 | 4 | 7989379 | |
| Pubmed | PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†. | 9.58e-10 | 4 | 195 | 4 | 36130203 | |
| Pubmed | 9.58e-10 | 4 | 195 | 4 | 10577388 | ||
| Pubmed | Structural organization, ion transport, and energy transduction of P-type ATPases. | 9.58e-10 | 4 | 195 | 4 | 8634322 | |
| Pubmed | 9.58e-10 | 4 | 195 | 4 | 12784250 | ||
| Pubmed | Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. | 9.58e-10 | 4 | 195 | 4 | 11152753 | |
| Pubmed | Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse. | 9.58e-10 | 4 | 195 | 4 | 10434059 | |
| Pubmed | 9.58e-10 | 4 | 195 | 4 | 15101689 | ||
| Pubmed | USP34 MYO1D MYCBP2 NOC2L ME2 GFPT1 IQGAP1 NUP205 DST SYNE2 USP7 PUM3 MED12 ANXA6 MSH6 LRPPRC ASNS ATP1A1 DDX21 CPSF3 | 9.90e-10 | 653 | 195 | 20 | 22586326 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | IQGAP1 NUP205 MAGED2 DIAPH1 USP7 ANAPC7 HSP90AB1 HSP90AB3P NRDC SMC2 MSH6 LRPPRC HSP90AB2P ATP1A1 DDX21 | 1.24e-09 | 344 | 195 | 15 | 36282215 |
| Pubmed | MYCBP2 IQGAP1 NUP205 DIAPH1 IQGAP3 LRPPRC ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 | 1.87e-09 | 202 | 195 | 12 | 24639526 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC6 MYCBP2 NOC2L SRM GFPT1 ASAP1 IQGAP1 NUP205 DST MAGED2 DIAPH1 USP7 PUM3 MED12 HSP90AB1 ANKFY1 SMC2 POLR3A WDR47 TGM1 MSH6 LRPPRC POLR3B ASNS HSP90AB2P DDX21 ATP2B1 CPSF3 | 2.75e-09 | 1353 | 195 | 28 | 29467282 |
| Pubmed | 4.77e-09 | 5 | 195 | 4 | 17938178 | ||
| Pubmed | 6.09e-09 | 101 | 195 | 9 | 9872452 | ||
| Pubmed | 1.23e-08 | 29 | 195 | 6 | 15071553 | ||
| Pubmed | Cardiac excitation-contraction coupling in the absence of Na(+) - Ca2+ exchange. | 1.42e-08 | 6 | 195 | 4 | 12767889 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | MYO10 F5 DST SYNE2 DMD PLOD2 RNF2 MYOM2 HSP90AB2P ATP2B1 ATP2B3 | 1.71e-08 | 197 | 195 | 11 | 20811636 |
| Pubmed | MYCBP2 BTBD1 CMYA5 TTC19 ASAP1 DST SYNE2 MED12L PUM3 HSP90AB1 ANKFY1 CAPN3 LRPPRC RNF2 MYOM2 ATP1A1 | 2.54e-08 | 497 | 195 | 16 | 23414517 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 5.26e-08 | 92 | 195 | 8 | 15840729 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | MYCBP2 SRM USP7 ANAPC7 HSP90AB1 HSP90AB3P SMC2 LRPPRC ATP1A1 ATP1A3 | 6.25e-08 | 175 | 195 | 10 | 25756610 |
| Pubmed | 6.59e-08 | 8 | 195 | 4 | 10951186 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 ZNF148 VRK3 TRIM24 USP7 PUM3 ANAPC7 KIF22 ARID4A CTDSPL2 ING5 MSH6 RNF2 SBNO1 FRG1 PHF14 CDK11B | 7.03e-08 | 608 | 195 | 17 | 36089195 |
| Pubmed | USP34 ATR SMNDC1 RNF114 GFPT1 IQGAP1 NUP205 DIAPH1 USP7 ANAPC7 MED12 SMC2 POLR3A POLR3F MSH6 POLR3B RNF2 SBNO1 ASNS PHF14 CDK11B CPSF3 | 7.06e-08 | 1014 | 195 | 22 | 32416067 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYO1D NOC2L SUCLA2 MEF2C GFPT1 MAGED2 USP7 PLOD2 HSP90AB1 HSP90AB3P MSH6 LRPPRC ASNS HSP90AB2P ATP1A1 CPSF3 | 1.46e-07 | 565 | 195 | 16 | 33567341 |
| Pubmed | KNTC1 USP34 VRK3 IQGAP2 NOC2L SUCLA2 IQGAP1 NUP205 DST SYNE2 USP7 PUM3 PLOD2 COG2 ANXA6 ING5 SMC2 POLR3A MSH6 LRPPRC POLR3B ASNS HSP90AB2P EIF3H ATP1A1 ATP2B1 | 1.59e-07 | 1440 | 195 | 26 | 30833792 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 25722290 | ||
| Pubmed | In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival. | 1.74e-07 | 3 | 195 | 3 | 22496871 | |
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 1.74e-07 | 3 | 195 | 3 | 25229330 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 15834131 | ||
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 22493426 | ||
| Pubmed | An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. | 1.74e-07 | 3 | 195 | 3 | 18093911 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 27989458 | ||
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 26286136 | ||
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 33315889 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | USP34 MYO1D NOC2L SLFN5 RNF114 TRIM24 NUP205 MAGED2 ANAPC7 ANKFY1 LRPPRC | 3.09e-07 | 262 | 195 | 11 | 36880596 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 IQGAP2 MYCBP2 NOC2L IQGAP1 NUP205 MAGED2 PUM3 IQGAP3 MED12 KIF22 EXOC6 SMC2 MSH6 POLR3B FRG1 EIF3H DDX21 | 3.27e-07 | 759 | 195 | 18 | 35915203 |
| Pubmed | MYO10 SLFN5 IQGAP1 DST DIAPH1 DMD HSP90AB1 HSP90AB3P SMC2 LRPPRC OTUD4 HSP90AB2P CDK11B EIF3H ATP2B2 | 4.42e-07 | 538 | 195 | 15 | 28524877 | |
| Pubmed | SYN3 MYO1D IQGAP2 SUCLA2 ASAP1 IQGAP1 DST SACS USP7 DMD HSP90AB1 NRDC OPHN1 WDR47 TGM1 LRPPRC THY1 OTUD4 ATP1A1 ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 DNAH11 | 5.18e-07 | 1431 | 195 | 25 | 37142655 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | IQGAP2 NOC2L IQGAP1 MAGED2 HSP90AB1 SMC2 LRPPRC ATP1A1 ATP1A3 DDX21 | 5.45e-07 | 221 | 195 | 10 | 29991511 |
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 8575763 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 10207130 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 21531906 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 25416778 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 31420455 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 8817457 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 22764880 | ||
| Pubmed | PSD95beta regulates plasma membrane Ca2+ pump localization at the photoreceptor synapse. | 6.91e-07 | 4 | 195 | 3 | 19233278 | |
| Pubmed | Requirement of MEF2A, C, and D for skeletal muscle regeneration. | 6.91e-07 | 4 | 195 | 3 | 24591619 | |
| Pubmed | Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. | 6.91e-07 | 4 | 195 | 3 | 7643214 | |
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 23300487 | ||
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 28970065 | ||
| Pubmed | IQGAP2 ME2 IQGAP1 MAGED2 DIAPH1 ANAPC7 PCYOX1 HSP90AB1 COG2 NRDC SMC2 MSH6 LRPPRC POLR3B ASNS | 7.29e-07 | 560 | 195 | 15 | 35241646 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYCBP2 MYO10 SRM BTBD1 RNF114 SUCLA2 IQGAP1 NUP205 USP7 SCLT1 ANAPC7 ANKFY1 NRDC POLR3A LRPPRC POLR3B FRG1 OTUD4 UGGT2 EIF3H | 1.10e-06 | 1005 | 195 | 20 | 19615732 |
| Pubmed | Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. | 1.25e-06 | 15 | 195 | 4 | 19782130 | |
| Pubmed | Control of the SOST bone enhancer by PTH using MEF2 transcription factors. | 1.72e-06 | 5 | 195 | 3 | 17696759 | |
| Pubmed | The MEF2B homologue differentially expressed in mouse embryonal carcinoma cells. | 1.72e-06 | 5 | 195 | 3 | 7646512 | |
| Pubmed | Galpha13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis. | 1.72e-06 | 5 | 195 | 3 | 19093215 | |
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 20833138 | ||
| Pubmed | Regulatory role of MEF2D in serum induction of the c-jun promoter. | 1.72e-06 | 5 | 195 | 3 | 7760790 | |
| Pubmed | MEF2 transcription factors are key regulators of sprouting angiogenesis. | 1.72e-06 | 5 | 195 | 3 | 27898394 | |
| Pubmed | Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. | 1.72e-06 | 5 | 195 | 3 | 9753748 | |
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 8993831 | ||
| Pubmed | Regulation of the MEF2 family of transcription factors by p38. | 1.72e-06 | 5 | 195 | 3 | 9858528 | |
| Pubmed | Calcineurin initiates skeletal muscle differentiation by activating MEF2 and MyoD. | 1.72e-06 | 5 | 195 | 3 | 12694204 | |
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 10458488 | ||
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 23511190 | ||
| Pubmed | 1.72e-06 | 5 | 195 | 3 | 8900141 | ||
| Pubmed | USP34 BTBD1 SUCLA2 TRIM24 DST SYNE2 DMD ABCB5 ANXA6 RNF2 ATP1A3 | 2.32e-06 | 322 | 195 | 11 | 26514267 | |
| Pubmed | 3.43e-06 | 6 | 195 | 3 | 12763866 | ||
| Pubmed | The expression of MEF2 genes is implicated in CNS neuronal differentiation. | 3.43e-06 | 6 | 195 | 3 | 9013788 | |
| Pubmed | 3.43e-06 | 6 | 195 | 3 | 20399744 | ||
| Pubmed | 3.43e-06 | 6 | 195 | 3 | 10737771 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.43e-06 | 212 | 195 | 9 | 33853758 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOC2L SMNDC1 IQGAP1 NUP205 USP7 PUM3 KIF22 HSP90AB1 MSH6 LRPPRC RNF2 FRG1 PHF14 HSP90AB2P CDK11B EIF3H ATP1A1 DDX21 CPSF3 | 3.45e-06 | 989 | 195 | 19 | 36424410 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DGKA SLFN5 GFPT1 NUP205 AFAP1L2 DST SCN3A HSP90AB1 IPPK CFAP47 ST3GAL4 MSH6 TNFSF11 EBLN1 ASNS PHF14 | 4.58e-06 | 736 | 195 | 16 | 29676528 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | SRM ADGRV1 BTBD1 IQGAP1 RHOBTB1 DIAPH1 CLEC16A HSP90AB1 ANKFY1 SMC2 LRPPRC EIF3H ATP1A1 | 5.05e-06 | 495 | 195 | 13 | 28581483 |
| Pubmed | Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. | 5.32e-06 | 21 | 195 | 4 | 17875930 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO1D MYCBP2 NOC2L F5 IQGAP1 NUP205 DST SACS SYNE2 PUM3 ANAPC7 KIF22 HSP90AB1 ANXA6 SMC2 LRPPRC ATP1A1 DDX21 ATP2B1 | 5.67e-06 | 1024 | 195 | 19 | 24711643 |
| Pubmed | POST, partner of stromal interaction molecule 1 (STIM1), targets STIM1 to multiple transporters. | 5.98e-06 | 7 | 195 | 3 | 22084111 | |
| Pubmed | Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. | 5.98e-06 | 7 | 195 | 3 | 8026334 | |
| Pubmed | USP34 ZNF148 MYO1D SMNDC1 IQGAP1 NUP205 MAGED2 USP7 PLOD2 ANAPC7 HSP90AB1 HSP90AB3P NRDC POLR3A MSH6 LRPPRC RNF2 ASNS HSP90AB2P EIF3H ATP1A1 DDX21 | 6.66e-06 | 1335 | 195 | 22 | 29229926 | |
| Pubmed | VRK3 MYO1D DCTN5 GFPT1 MEF2D IQGAP1 DIAPH1 USP7 AFF1 MED12 KIF22 HSP90AB1 NT5E SMC2 LRPPRC RNF2 ASNS OTUD4 ATP1A1 ATP1A3 DDX21 | 7.89e-06 | 1247 | 195 | 21 | 27684187 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZNF148 ATR MYCBP2 MEF2D IQGAP1 MAGED2 USP7 AFF1 HSP90AB1 ARID4A SAP30L MSH6 OTUD4 PHF14 CDK11B DDX21 | 8.59e-06 | 774 | 195 | 16 | 15302935 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | IQGAP2 MYCBP2 SRM SUCLA2 GFPT1 NUP205 MAGED2 USP7 ANAPC7 IQGAP3 MED12 HSP90AB1 SMC2 POLR3A MSH6 LRPPRC ASNS HSP90AB2P ATP1A1 DDX21 CPSF3 | 8.90e-06 | 1257 | 195 | 21 | 37317656 |
| Pubmed | 9.52e-06 | 8 | 195 | 3 | 16043483 | ||
| Pubmed | MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. | 9.52e-06 | 8 | 195 | 3 | 30205047 | |
| Pubmed | Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. | 9.52e-06 | 8 | 195 | 3 | 17786239 | |
| Pubmed | USP34 MYO10 NOC2L SMNDC1 MAGED2 USP7 ANAPC7 IQGAP3 KIF22 HSP90AB1 TEC SMC2 MSH6 LRPPRC FRG1 DDX21 ATP2B1 CPSF3 | 1.02e-05 | 971 | 195 | 18 | 33306668 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | IQGAP2 DCTN5 SUCLA2 TRIM24 GFPT1 IQGAP1 NUP205 PUM3 IQGAP3 SMC2 POLR3A MSH6 POLR3B ASNS ATP1A1 | 1.16e-05 | 704 | 195 | 15 | 29955894 |
| Pubmed | MYO1D GFPT1 IQGAP1 NUP205 HSP90AB1 TGM1 LRPPRC ATP1A1 DDX21 ATP2B1 | 1.18e-05 | 312 | 195 | 10 | 37120454 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | KNTC1 VRK3 MYO1D IQGAP2 MYCBP2 NOC2L SMNDC1 CDK19 CMYA5 IQGAP1 NUP205 USP7 PLOD2 MMS22L SMC2 MSH6 LRPPRC OTUD4 CDK11B EIF3H DDX21 | 1.22e-05 | 1284 | 195 | 21 | 17353931 |
| Pubmed | NOC2L SRM NUP205 HSP90AB1 LRPPRC ASNS HSP90AB2P ZMYM1 CDK11B ATP1A1 DDX21 ATP2B1 | 1.34e-05 | 463 | 195 | 12 | 34901782 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF148 VRK3 ATR NOC2L SMNDC1 SLFN5 DST USP7 ANAPC7 KIF22 ARID4A CTDSPL2 ING5 SAP30L SMC2 ZBTB14 RNF2 FRG1 PHF14 DDX21 CPSF3 | 1.37e-05 | 1294 | 195 | 21 | 30804502 |
| Pubmed | 1.37e-05 | 92 | 195 | 6 | 20301317 | ||
| Interaction | CALM1 interactions | MYO1D IQGAP2 MYCBP2 MYO10 TRIM24 DMXL1 IQGAP1 DST SYNE2 PUM3 SCLT1 IQGAP3 OPRM1 LRPPRC RNF2 NT5C2 DDX21 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.27e-07 | 626 | 185 | 21 | int:CALM1 |
| Interaction | CRY2 interactions | MYCBP2 SRM USP7 ANAPC7 HSP90AB1 HSP90AB3P SMC2 LRPPRC OTUD4 ATP1A1 ATP1A3 | 1.86e-06 | 194 | 185 | 11 | int:CRY2 |
| Interaction | C17orf78 interactions | 3.21e-06 | 12 | 185 | 4 | int:C17orf78 | |
| Interaction | OPALIN interactions | KNTC1 ATR SLFN5 NUP205 DPY19L1 TMEM39B ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 3.82e-06 | 209 | 185 | 11 | int:OPALIN |
| Interaction | SIRT7 interactions | USP34 ATR MYO1D MYCBP2 NOC2L ME2 GFPT1 IQGAP1 NUP205 DST SYNE2 USP7 PUM3 MED12 ANXA6 MSH6 LRPPRC ASNS ATP1A1 DDX21 CPSF3 | 5.09e-06 | 744 | 185 | 21 | int:SIRT7 |
| Interaction | POLR2H interactions | ERCC6 IQGAP2 CDK19 MED12L CLEC16A MED12 POLR3A POLR3F LRPPRC POLR3B RNF2 | 7.10e-06 | 223 | 185 | 11 | int:POLR2H |
| Interaction | HSD17B6 interactions | 8.67e-06 | 15 | 185 | 4 | int:HSD17B6 | |
| Interaction | RUFY1 interactions | IQGAP1 NUP205 MAGED2 DIAPH1 USP7 ANAPC7 HSP90AB1 HSP90AB3P ANKFY1 NRDC SMC2 MSH6 LRPPRC HSP90AB2P ATP1A1 DDX21 | 8.68e-06 | 476 | 185 | 16 | int:RUFY1 |
| Interaction | C3orf18 interactions | 1.11e-05 | 115 | 185 | 8 | int:C3orf18 | |
| Interaction | ATP2B3 interactions | 1.43e-05 | 86 | 185 | 7 | int:ATP2B3 | |
| Interaction | SELENOF interactions | 2.21e-05 | 62 | 185 | 6 | int:SELENOF | |
| Interaction | HCRTR2 interactions | 2.76e-05 | 39 | 185 | 5 | int:HCRTR2 | |
| Interaction | LGR4 interactions | MYCBP2 IQGAP1 NUP205 IQGAP3 LRPPRC ATP1A1 ATP1A3 DDX21 ATP2B1 ATP2B2 ATP2B3 | 3.19e-05 | 262 | 185 | 11 | int:LGR4 |
| Interaction | BIRC3 interactions | KNTC1 ATR MYO1D NOC2L CMYA5 SUCLA2 ME2 GFPT1 IQGAP1 NUP205 MAGED2 DIAPH1 USP7 ANAPC7 PCYOX1 HSP90AB1 ANXA6 SMC2 MSH6 LRPPRC RNF2 ASNS EIF3H ATP1A1 DDX21 ATP2B1 ATP2B3 CPSF3 | 3.44e-05 | 1334 | 185 | 28 | int:BIRC3 |
| Interaction | CYP2B6 interactions | 4.12e-05 | 8 | 185 | 3 | int:CYP2B6 | |
| Interaction | FAM174A interactions | ATR SLFN5 EXOC6 SMC2 MSH6 ATP1A3 ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 4.38e-05 | 224 | 185 | 10 | int:FAM174A |
| Interaction | PTGES3 interactions | ERCC6 DCTN5 SLFN5 ANAPC7 KIF22 HSP90AB1 HSP90AB3P POLR3A MSH6 LRPPRC POLR3B SBNO1 NT5C2 HSP90AB2P | 5.42e-05 | 437 | 185 | 14 | int:PTGES3 |
| Interaction | NPTN interactions | KNTC1 ATR AGTR1 SEC14L1 EXOC6 COG2 MMS22L ATP2B1 ATP2B2 ATP2B3 ATP2B4 | 5.46e-05 | 278 | 185 | 11 | int:NPTN |
| Interaction | ZNF330 interactions | ZNF148 NOC2L SMNDC1 TRIM24 NUP205 PUM3 KIF22 TRIM42 MSH6 LRPPRC RNF2 FRG1 PHF14 DDX21 | 6.75e-05 | 446 | 185 | 14 | int:ZNF330 |
| Interaction | SIRT6 interactions | MYCBP2 NOC2L GFPT1 NUP205 MAGED2 USP7 PUM3 PLOD2 ANAPC7 IQGAP3 MED12 FAT3 SMC2 HPS3 MSH6 CDK11B THAP12 | 7.10e-05 | 628 | 185 | 17 | int:SIRT6 |
| Interaction | AURKB interactions | ZNF148 NOC2L ADGRV1 CMYA5 NUP205 CLEC16A ANAPC7 HSP90AB1 HSP90AB3P POLR3A MSH6 LRPPRC RNF2 MYO1F MYOM2 CRYBG3 ATP1A1 DDX21 THAP12 | 7.75e-05 | 761 | 185 | 19 | int:AURKB |
| Interaction | KLHDC7A interactions | 8.38e-05 | 2 | 185 | 2 | int:KLHDC7A | |
| Interaction | BTNL9 interactions | 9.89e-05 | 156 | 185 | 8 | int:BTNL9 | |
| Interaction | GPR173 interactions | 1.03e-04 | 51 | 185 | 5 | int:GPR173 | |
| Interaction | GPR45 interactions | KNTC1 ATR SLFN5 NUP205 ANAPC7 COG2 MMS22L DPY19L1 MSH6 ATP1A3 ATP2B2 | 1.08e-04 | 300 | 185 | 11 | int:GPR45 |
| Interaction | B4GALT2 interactions | 1.16e-04 | 119 | 185 | 7 | int:B4GALT2 | |
| Interaction | LILRB4 interactions | 1.18e-04 | 28 | 185 | 4 | int:LILRB4 | |
| Interaction | ANKRD1 interactions | 1.18e-04 | 28 | 185 | 4 | int:ANKRD1 | |
| Interaction | MEF2B interactions | 1.19e-04 | 11 | 185 | 3 | int:MEF2B | |
| Interaction | STYK1 interactions | 1.23e-04 | 161 | 185 | 8 | int:STYK1 | |
| Interaction | ENTPD7 interactions | 1.24e-04 | 53 | 185 | 5 | int:ENTPD7 | |
| Interaction | CXCR4 interactions | KNTC1 IQGAP1 IPPK EXOC6 OSTM1 NT5E SMC2 ATP1A3 ATP2B2 ATP2B3 | 1.29e-04 | 255 | 185 | 10 | int:CXCR4 |
| Interaction | MOB2 interactions | 1.50e-04 | 87 | 185 | 6 | int:MOB2 | |
| Interaction | PDGFB interactions | 1.60e-04 | 88 | 185 | 6 | int:PDGFB | |
| Interaction | PBXIP1 interactions | 1.78e-04 | 216 | 185 | 9 | int:PBXIP1 | |
| Interaction | ITGB3 interactions | 1.79e-04 | 170 | 185 | 8 | int:ITGB3 | |
| Interaction | H3-3A interactions | ERCC6 ZNF148 VRK3 TRIM24 USP7 PUM3 ANAPC7 KIF22 CTDSPL2 ING5 MSH6 LRPPRC RNF2 SBNO1 DPF3 FRG1 PHF14 CDK11B | 1.93e-04 | 749 | 185 | 18 | int:H3-3A |
| Interaction | C9orf78 interactions | IQGAP2 BTBD1 ME2 IQGAP1 MAGED2 DIAPH1 ANAPC7 PCYOX1 HSP90AB1 COG2 NRDC SMC2 MSH6 LRPPRC POLR3B ASNS | 2.01e-04 | 620 | 185 | 16 | int:C9orf78 |
| Interaction | KIF23 interactions | NOC2L SMNDC1 GFPT1 IQGAP1 MAGED2 USP7 PUM3 DMD SCLT1 IQGAP3 HSP90AB1 HSP90AB3P SMC2 MSH6 LRPPRC ASNS MYO1F OTUD4 HSP90AB2P DDX21 ATP2B3 THAP12 | 2.04e-04 | 1031 | 185 | 22 | int:KIF23 |
| Interaction | HDAC1 interactions | ERCC6 ZNF148 ATR MYCBP2 MEF2A MEF2D IQGAP1 DST SYNE2 USP7 AFF1 MED12 HSP90AB1 ANKFY1 ARID4A SAP30L SMC2 POLR3A MSH6 LRPPRC RNF2 PHF14 CRYBG3 | 2.16e-04 | 1108 | 185 | 23 | int:HDAC1 |
| Interaction | TRIM52 interactions | 2.31e-04 | 133 | 185 | 7 | int:TRIM52 | |
| Interaction | SOCS1 interactions | 2.36e-04 | 177 | 185 | 8 | int:SOCS1 | |
| Interaction | CLUAP1 interactions | 2.50e-04 | 226 | 185 | 9 | int:CLUAP1 | |
| Interaction | PNPLA4 interactions | 2.57e-04 | 14 | 185 | 3 | int:PNPLA4 | |
| Interaction | MAP2K2 interactions | ATR IQGAP2 IQGAP1 RHOBTB1 MAGED2 DIAPH1 HSP90AB1 HSP90AB3P HPS3 LRPPRC | 2.58e-04 | 278 | 185 | 10 | int:MAP2K2 |
| Interaction | H3-4 interactions | NOC2L SMNDC1 MEF2A AFF1 DMD KIF22 HSP90AB1 MMS22L CAPN3 POLR3F RNF2 DPF3 UGGT2 | 2.65e-04 | 448 | 185 | 13 | int:H3-4 |
| Interaction | GRWD1 interactions | IQGAP2 NOC2L IQGAP1 RHOBTB1 MAGED2 USP7 HSP90AB1 SMC2 LRPPRC ATP1A1 ATP1A3 DDX21 | 2.70e-04 | 390 | 185 | 12 | int:GRWD1 |
| GeneFamily | ATPases Ca2+ transporting | 4.21e-07 | 9 | 140 | 4 | 1209 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 1.81e-06 | 4 | 140 | 3 | 649 | |
| GeneFamily | Myocyte enhancer factor 2 proteins|MADS box family | 4.49e-06 | 5 | 140 | 3 | 1086 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.54e-04 | 4 | 140 | 2 | 1244 | |
| GeneFamily | Somatostatin receptors | 5.86e-04 | 5 | 140 | 2 | 257 | |
| GeneFamily | Schlafen family | 1.22e-03 | 7 | 140 | 2 | 1110 | |
| GeneFamily | CD molecules|5'-nucleotidases | 1.22e-03 | 7 | 140 | 2 | 1042 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.22e-03 | 7 | 140 | 2 | 1208 | |
| GeneFamily | RNA polymerase subunits | 1.43e-03 | 29 | 140 | 3 | 726 | |
| GeneFamily | Fibronectin type III domain containing | 1.55e-03 | 160 | 140 | 6 | 555 | |
| GeneFamily | Myosins, class I | 1.62e-03 | 8 | 140 | 2 | 1097 | |
| GeneFamily | Cyclins|Mediator complex | 2.09e-03 | 33 | 140 | 3 | 1061 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.62e-03 | 394 | 140 | 9 | 471 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.90e-03 | 134 | 140 | 5 | 861 | |
| GeneFamily | Immunoglobulin like domain containing | 3.94e-03 | 193 | 140 | 6 | 594 | |
| GeneFamily | PHD finger proteins | 5.26e-03 | 90 | 140 | 4 | 88 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 7.50e-03 | 17 | 140 | 2 | 1291 | |
| GeneFamily | CD molecules|Endogenous ligands|Tumor necrosis factor superfamily|Death inducing signaling complex | 8.40e-03 | 18 | 140 | 2 | 781 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 ZNF148 ATR MYCBP2 MYO10 CDK19 TRIM24 ME2 MEF2A MGAT5 DST SACS SYNE2 USP7 AFF1 PUM3 DMD PLOD2 CLEC16A SEC14L1 ARID4A MSH6 LRPPRC RNF2 NT5C2 OTUD4 PHF14 CRYBG3 DDX21 ATP2B1 ATP2B4 | 1.68e-13 | 856 | 191 | 31 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR | 1.84e-06 | 152 | 191 | 9 | M39243 | |
| Coexpression | GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN | USP34 IPPK MMS22L NRDC SMC2 POLR3F TRMT44 MYO1F UGGT2 THAP12 | 2.26e-06 | 200 | 191 | 10 | M3891 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | USP34 MYO1D MYCBP2 BTBD1 DNAJB9 GFPT1 ASAP1 DST PTPRJ SYNE2 AFF1 PLOD2 HSP90AB1 OSTM1 NRDC LRPPRC RNF2 SBNO1 WSCD2 EIF3H PDZRN3 | 6.15e-06 | 946 | 191 | 21 | M39169 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | USP34 ZNF148 ATR MYCBP2 PECAM1 DGKA SLFN5 BTBD1 RNF114 MEF2D ASAP1 IQGAP1 CD84 PTPRJ SACS DIAPH1 OSTM1 NRDC ARID4A ANXA6 SBNO1 CRTAM MYO1F OTUD4 EIF3H THAP12 ATP2B4 | 1.19e-05 | 1492 | 191 | 27 | M40023 |
| Coexpression | GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN | 1.58e-05 | 198 | 191 | 9 | M3119 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP | 1.64e-05 | 199 | 191 | 9 | M8748 | |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 1.71e-05 | 200 | 191 | 9 | M9348 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.71e-05 | 200 | 191 | 9 | M8854 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 1.71e-05 | 200 | 191 | 9 | M5192 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | KNTC1 ATR ME2 GFPT1 IQGAP3 OSTM1 DPY19L1 CTDSPL2 SMC2 HPS3 MSH6 LRPPRC ASNS UGGT2 PHF14 CPSF3 | 2.17e-05 | 644 | 191 | 16 | M10501 |
| Coexpression | DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS | 2.70e-05 | 212 | 191 | 9 | M40226 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN | 3.07e-05 | 25 | 191 | 4 | M7678 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN | 3.53e-05 | 169 | 191 | 8 | M379 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | SLFN5 MEF2C MEF2D DST RHOBTB1 AFF1 NT5E FAT3 LPAR6 CRYBG3 ATP2B1 | 3.98e-05 | 337 | 191 | 11 | M13206 |
| Coexpression | GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 4.34e-05 | 174 | 191 | 8 | M9007 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYO1D IQGAP2 MYO10 SLFN5 MEF2C DMXL1 MGAT5 AFAP1L2 DST PTPRJ AGTR1 MED12L FGD5 PLOD2 ARID4A NT5E MINDY2 MYOM2 | 5.73e-05 | 854 | 191 | 18 | M1533 |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | IL12B DRAM1 MYO10 DGKA SLFN5 TNFSF4 PTPRJ AFF1 PLOD2 ABTB2 TBC1D13 SLFN12L | 6.16e-05 | 418 | 191 | 12 | M12676 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 6.19e-05 | 183 | 191 | 8 | M8886 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS | 6.77e-05 | 137 | 191 | 7 | M41743 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 7.76e-05 | 189 | 191 | 8 | M3112 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 7.89e-05 | 97 | 191 | 6 | M14698 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | MYO1D IQGAP2 MYO10 SLFN5 MEF2C DMXL1 MGAT5 AFAP1L2 DST PTPRJ AGTR1 MED12L FGD5 PLOD2 ARID4A NT5E MINDY2 MYOM2 | 9.38e-05 | 888 | 191 | 18 | MM1018 |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 9.65e-05 | 195 | 191 | 8 | M7382 | |
| Coexpression | MURARO_PANCREAS_DELTA_CELL | 9.67e-05 | 250 | 191 | 9 | M39170 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 ZNF148 ATR IQGAP2 MYCBP2 MYO10 TRIM24 DMXL1 SACS SYNE2 PUM3 OSTM1 SMC2 ZMYM1 DDX21 | 9.99e-05 | 656 | 191 | 15 | M18979 |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP | 1.07e-04 | 198 | 191 | 8 | M5044 | |
| Coexpression | GSE25087_TREG_VS_TCONV_ADULT_UP | 1.11e-04 | 199 | 191 | 8 | M4650 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN | 1.11e-04 | 199 | 191 | 8 | M8743 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | 1.11e-04 | 199 | 191 | 8 | M5143 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN | 1.11e-04 | 199 | 191 | 8 | M3107 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP | 1.11e-04 | 199 | 191 | 8 | M3050 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 1.15e-04 | 200 | 191 | 8 | M4512 | |
| Coexpression | GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M8521 | |
| Coexpression | GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M7505 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M7432 | |
| Coexpression | GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M5043 | |
| Coexpression | GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP | 1.15e-04 | 200 | 191 | 8 | M9041 | |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.15e-04 | 200 | 191 | 8 | M9165 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.41e-04 | 206 | 191 | 8 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.51e-04 | 208 | 191 | 8 | MM581 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZNF148 ATR MYCBP2 MYO10 MGAT5 DST AFF1 PUM3 CLEC16A SEC14L1 LRPPRC ATP2B1 | 1.70e-04 | 466 | 191 | 12 | M13522 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN | 1.85e-04 | 161 | 191 | 7 | M8250 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 2.00e-04 | 163 | 191 | 7 | M2997 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 2.02e-04 | 115 | 191 | 6 | M19068 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP | 2.32e-04 | 167 | 191 | 7 | M2995 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | KNTC1 ATR DRAM1 TRIM24 ME2 ASAP1 TNFSF4 NUP205 SACS DMD ANAPC7 IQGAP3 DPY19L1 CTDSPL2 SMC2 ADAM12 MSH6 LRPPRC THY1 ASNS PHF14 DDX21 CPSF3 | 2.50e-04 | 1407 | 191 | 23 | M14427 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | USP34 ATR SLFN5 GFPT1 ASAP1 IQGAP1 PUM3 CTDSPL2 SMC2 HPS3 MSH6 ASNS UGGT2 ATP2B1 CPSF3 | 2.77e-04 | 721 | 191 | 15 | M10237 |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 2.78e-04 | 172 | 191 | 7 | M8234 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 2.85e-04 | 289 | 191 | 9 | M2196 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CDK19 DGKA SLFN5 ME2 MEF2A GFPT1 TNFSF4 CD84 PTPRJ NYAP1 SEC14L1 NRDC NT5E ST3GAL4 TEC MINDY2 MSH6 POLR3B FRG1 CDK11B EIF3H | 2.92e-04 | 1239 | 191 | 21 | M1743 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN | 3.19e-04 | 176 | 191 | 7 | M8884 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 3.19e-04 | 176 | 191 | 7 | M2981 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 3.42e-04 | 178 | 191 | 7 | M6326 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP | ZNF148 MYCBP2 MEF2C TTC19 USP7 EXOC6 ZNF322 MSH6 LRPPRC FRG1 PHF14 IAH1 THAP12 CPSF3 | 3.54e-04 | 658 | 191 | 14 | M40871 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | FSTL5 ADGRV1 MED12L AFF1 TACR1 PLOD2 FAT3 FLVCR2 OPHN1 ATP2B2 | 3.59e-04 | 364 | 191 | 10 | M39057 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | CDK19 DNAJB9 F8 MEF2C DST AGTR1 NT5E ANXA6 MINDY2 PHF14 CDK11B PDZRN3 | 3.60e-04 | 506 | 191 | 12 | M253 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | USP34 ZNF148 ATR SMNDC1 SUCLA2 ADAMTS20 PCYOX1 CTDSPL2 SMC2 SBNO1 PHF14 | 3.64e-04 | 434 | 191 | 11 | M15150 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.66e-04 | 180 | 191 | 7 | M8239 | |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN | 3.66e-04 | 180 | 191 | 7 | M6317 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 3.66e-04 | 180 | 191 | 7 | M9145 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | IL12B DRAM1 MYO10 DGKA SLFN5 TNFSF4 PTPRJ AFF1 PLOD2 ABTB2 TBC1D13 | 3.71e-04 | 435 | 191 | 11 | MM1221 |
| Coexpression | GSE25677_MPL_VS_R848_STIM_BCELL_DN | 3.78e-04 | 181 | 191 | 7 | M8187 | |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP | 3.78e-04 | 181 | 191 | 7 | M6323 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | KNTC1 SRM ASAP1 SYNE2 ELAPOR1 ADAMTS20 IQGAP3 CA4 KIF22 FAT3 KCNT2 | 3.85e-04 | 437 | 191 | 11 | M1610 |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 3.99e-04 | 85 | 191 | 5 | M1723 | |
| Coexpression | LEIN_CEREBELLUM_MARKERS | 3.99e-04 | 85 | 191 | 5 | MM720 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | CDK19 DGKA SLFN5 ME2 MEF2A GFPT1 TNFSF4 CD84 PTPRJ NYAP1 SEC14L1 NRDC NT5E ST3GAL4 TEC MINDY2 MSH6 POLR3B FRG1 CDK11B EIF3H | 4.36e-04 | 1277 | 191 | 21 | MM1032 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | USP34 ZNF148 ATR SMNDC1 SUCLA2 ADAMTS20 PCYOX1 CTDSPL2 SMC2 SBNO1 PHF14 | 4.74e-04 | 448 | 191 | 11 | MM1044 |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 4.86e-04 | 311 | 191 | 9 | M40024 | |
| Coexpression | GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN | 4.90e-04 | 189 | 191 | 7 | M6494 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 5.09e-04 | 313 | 191 | 9 | M39128 | |
| Coexpression | TURJANSKI_MAPK11_TARGETS | 5.21e-04 | 5 | 191 | 2 | M2492 | |
| Coexpression | CUI_TCF21_TARGETS_2_UP | KNTC1 SRM ASAP1 SYNE2 ELAPOR1 ADAMTS20 IQGAP3 CA4 KIF22 FAT3 KCNT2 | 5.39e-04 | 455 | 191 | 11 | MM1189 |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 5.72e-04 | 194 | 191 | 7 | M7288 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP | 5.72e-04 | 194 | 191 | 7 | M4221 | |
| Coexpression | GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 5.90e-04 | 195 | 191 | 7 | M9527 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | SYN3 IQGAP2 PECAM1 DNAJB9 AFF1 ANXA6 FLVCR2 CRTAM MYO1F PDZRN3 | 6.02e-04 | 389 | 191 | 10 | M4995 |
| Coexpression | GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP | 6.08e-04 | 196 | 191 | 7 | M5189 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 6.21e-04 | 257 | 191 | 8 | M13867 | |
| Coexpression | GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN | 6.45e-04 | 198 | 191 | 7 | M8173 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP | 6.45e-04 | 198 | 191 | 7 | M3436 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 6.45e-04 | 198 | 191 | 7 | M9778 | |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 6.45e-04 | 198 | 191 | 7 | M6511 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN | 6.65e-04 | 199 | 191 | 7 | M9332 | |
| Coexpression | GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN | 6.65e-04 | 199 | 191 | 7 | M3294 | |
| Coexpression | GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 6.65e-04 | 199 | 191 | 7 | M6197 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN | 6.65e-04 | 199 | 191 | 7 | M8709 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP | 6.65e-04 | 199 | 191 | 7 | M8734 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 6.65e-04 | 199 | 191 | 7 | M5201 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN | 6.65e-04 | 199 | 191 | 7 | M4188 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN | 6.65e-04 | 199 | 191 | 7 | M6711 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 6.85e-04 | 200 | 191 | 7 | M8027 | |
| Coexpression | GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN | 6.85e-04 | 200 | 191 | 7 | M7055 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP | 6.85e-04 | 200 | 191 | 7 | M8322 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_BCELL_UP | 6.85e-04 | 200 | 191 | 7 | M8260 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN | 6.85e-04 | 200 | 191 | 7 | M8267 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 6.85e-04 | 200 | 191 | 7 | M9563 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 6.85e-04 | 200 | 191 | 7 | M7294 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 6.85e-04 | 200 | 191 | 7 | M8554 | |
| CoexpressionAtlas | alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3 | MYO10 DGKA SPO11 TRIM24 MEF2A MEF2D AFF1 NYAP1 ABTB2 CAPN3 ADAM12 MSH6 THY1 LPAR6 | 2.28e-06 | 343 | 187 | 14 | GSM399400_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | IQGAP2 MYCBP2 MYO10 TTC19 IQGAP1 MED12L ADAMTS20 DPY19L1 CTDSPL2 SMC2 POLR3F SBNO1 OTUD4 | 2.98e-05 | 375 | 187 | 13 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | ERCC6 IQGAP2 MEF2A MEF2C XYLT1 AFAP1L2 DST SYNE2 ELAPOR1 AFF1 PLOD2 ABTB2 NRDC NT5E ST3GAL4 FLVCR2 HPS3 ASNS OTUD4 ATP1A1 ATP2B3 | 3.40e-05 | 880 | 187 | 21 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | KNTC1 ATR SMNDC1 PECAM1 DGKA SPO11 NUP205 PUM3 HFM1 MMS22L POLR3F MSH6 LRPPRC POLR3B ASNS OTUD4 ZMYM1 DDX21 TMEM63A | 8.05e-05 | 795 | 187 | 19 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | KNTC1 ERCC6 ATR PECAM1 DGKA SPO11 RNF114 ME2 NUP205 PUM3 HFM1 ARID4A POLR3F LRPPRC POLR3B SBNO1 OTUD4 ZMYM1 DDX21 | 1.03e-04 | 810 | 187 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | alpha beta T cells, T.DP.Th, 4+ 8+ TCR-/lo 69-, Thymus, avg-3 | KNTC1 DGKA SPO11 MEF2A AFF1 NYAP1 ABTB2 KIF22 ADAM12 MSH6 THY1 LPAR6 | 1.05e-04 | 367 | 187 | 12 | GSM399391_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | IQGAP2 MYCBP2 MYO10 TTC19 IQGAP1 ANKFY1 DPY19L1 CTDSPL2 SBNO1 OTUD4 | 1.11e-04 | 261 | 187 | 10 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_500 | MYO1D DRAM1 IQGAP2 PECAM1 SLFN5 F8 MGAT5 PTPRJ AGTR1 NT5E MINDY2 SLFN12L MYOM2 | 1.43e-04 | 438 | 187 | 13 | gudmap_kidney_adult_RenCorpuscGlomer_500 |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_200 | 1.47e-04 | 172 | 187 | 8 | gudmap_kidney_adult_RenCorpuscGlomer_200 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | IQGAP2 DGKA CD84 XYLT1 ABTB2 NT5E ANXA6 THY1 CRTAM MYO1F ATP2B1 ATP2B4 | 1.73e-04 | 387 | 187 | 12 | GSM538392_500 |
| ToppCell | Mesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class | 8.34e-09 | 183 | 194 | 10 | d6b52d52fe9a7a6c798947f05420d79fe12e4662 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-08 | 166 | 194 | 9 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.21e-08 | 173 | 194 | 9 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.65e-08 | 179 | 194 | 9 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-07 | 182 | 194 | 9 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-ELP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-07 | 188 | 194 | 9 | 0a47de24812c619f6756c9351a413b109128d54f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-07 | 189 | 194 | 9 | c45734970036e6d28d5e3fe7c9458fae38a3f624 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-ELP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-07 | 192 | 194 | 9 | 38ec82aa2ec4f2c0a843e83f7fe54f6b2483ca3d | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.75e-07 | 192 | 194 | 9 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.00e-07 | 195 | 194 | 9 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.52e-07 | 173 | 194 | 8 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.52e-07 | 173 | 194 | 8 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 177 | 194 | 8 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 178 | 194 | 8 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 178 | 194 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-06 | 178 | 194 | 8 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-06 | 179 | 194 | 8 | df4d0b2fe47d2c7def729b3217cb01ced01495ff | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 181 | 194 | 8 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-06 | 182 | 194 | 8 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 1.51e-06 | 184 | 194 | 8 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.78e-06 | 188 | 194 | 8 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.78e-06 | 188 | 194 | 8 | de7cb273899d0e0748c85f45c6b5e7f0642ab057 | |
| ToppCell | (6)_ILC|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.78e-06 | 188 | 194 | 8 | f4734d5b703678670ece204a0519cf015e180a6e | |
| ToppCell | Mesenchymal_cells-Osteoblasts|World / Lineage and Cell class | 1.78e-06 | 188 | 194 | 8 | 89f7f5a51be7e046a63e2413f86c521ae4b6718f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-06 | 189 | 194 | 8 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-06 | 190 | 194 | 8 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.00e-06 | 191 | 194 | 8 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 192 | 194 | 8 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 193 | 194 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 193 | 194 | 8 | 52e918884877b6659cdca0496390e440f73694a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 195 | 194 | 8 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.33e-06 | 195 | 194 | 8 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.42e-06 | 196 | 194 | 8 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.50e-06 | 138 | 194 | 7 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 198 | 194 | 8 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.61e-06 | 198 | 194 | 8 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 200 | 194 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 200 | 194 | 8 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 200 | 194 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 200 | 194 | 8 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.81e-06 | 200 | 194 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 155 | 194 | 7 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.40e-06 | 155 | 194 | 7 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.38e-06 | 159 | 194 | 7 | 8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-06 | 161 | 194 | 7 | 52556b89808e551540f33a13f57417a6696c2438 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-06 | 161 | 194 | 7 | 242891be849a4398fe8bea44875ae1ba57950944 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-06 | 161 | 194 | 7 | 54f156cf2bd5a6ba9a78ec4e3ee28b89998aec2e | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 7.51e-06 | 163 | 194 | 7 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.81e-06 | 164 | 194 | 7 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.46e-06 | 166 | 194 | 7 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | Adult-Immune-natural_killer_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.80e-06 | 167 | 194 | 7 | ff1ce3b1a2d91d2ad979f25899db4f4eeb865892 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 173 | 194 | 7 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 174 | 194 | 7 | a3f4981b10afa9d41a1c66c7f98522a8a534f82b | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 174 | 194 | 7 | 6cc108dde4b3f98a78a6040280f0d5e4aaa5bd75 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 174 | 194 | 7 | 4b8bc5568e36031c8ecf001bb646809038c23919 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 174 | 194 | 7 | 5e6050d20a5b27640f6a200441125b8ceba123c8 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 116 | 194 | 6 | df7609503782d8d7e4f31ed2a626916e5474d5bc | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 177 | 194 | 7 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-05 | 177 | 194 | 7 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.28e-05 | 177 | 194 | 7 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 177 | 194 | 7 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 177 | 194 | 7 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 177 | 194 | 7 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.28e-05 | 177 | 194 | 7 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-05 | 177 | 194 | 7 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | lung|World / shred on tissue and cell subclass | 1.33e-05 | 178 | 194 | 7 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 178 | 194 | 7 | 9e1f2596fcea5b79cc50b58d83706bb8605e224f | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 178 | 194 | 7 | aa659bd283c4dfbe292cd8698bbf6b1999ca3314 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 178 | 194 | 7 | bf1d273802a4f42e52ea1bd2a0cae2039559c093 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 179 | 194 | 7 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 179 | 194 | 7 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.43e-05 | 180 | 194 | 7 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 180 | 194 | 7 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 180 | 194 | 7 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | AT1_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 180 | 194 | 7 | e1964002681f80d8d62406b6ee52a01e1829ccf2 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 180 | 194 | 7 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 71 | 194 | 5 | b0dbb059a7d05f825da608879b23aeebd6e9e61f | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Igfbp4-Inhibitory_Neuron.Gad1Gad2.Igfbp4.Rgs4_(Striatum,_interneuron)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.46e-05 | 71 | 194 | 5 | 149504ce72da0730074ea436fc2034ce8cb585d5 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.48e-05 | 181 | 194 | 7 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 182 | 194 | 7 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 182 | 194 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 182 | 194 | 7 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 183 | 194 | 7 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 183 | 194 | 7 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | IPF-Lymphoid-ILC_B|Lymphoid / Disease state, Lineage and Cell class | 1.59e-05 | 183 | 194 | 7 | 9b507547e6adf78e46e7f542cd9958224ec5826a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 1.65e-05 | 184 | 194 | 7 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.65e-05 | 184 | 194 | 7 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 184 | 194 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-05 | 185 | 194 | 7 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 185 | 194 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.71e-05 | 185 | 194 | 7 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 186 | 194 | 7 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 187 | 194 | 7 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | ASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.89e-05 | 188 | 194 | 7 | 13f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 188 | 194 | 7 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 188 | 194 | 7 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| Drug | AC1L88YH | 2.13e-07 | 17 | 189 | 5 | CID000374551 | |
| Drug | 2brh | 6.83e-07 | 21 | 189 | 5 | CID000848641 | |
| Drug | 1sqc | 9.29e-07 | 10 | 189 | 4 | CID000444279 | |
| Drug | 2,5-dimethylquinone | 1.45e-06 | 11 | 189 | 4 | CID000008718 | |
| Drug | dodecyl ether | 2.13e-06 | 26 | 189 | 5 | CID000020667 | |
| Drug | 1vyq | 2.16e-06 | 12 | 189 | 4 | CID004369390 | |
| Drug | Ro 46861 | 2.16e-06 | 12 | 189 | 4 | CID000003128 | |
| Drug | 8-hydroxycoumarin | 3.10e-06 | 13 | 189 | 4 | CID000122783 | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | USP34 ZNF148 CDK19 MGAT5 PLOD2 PCYOX1 TBC1D13 MSH6 ATP2B1 ATP2B4 | 4.07e-06 | 188 | 189 | 10 | 4845_DN |
| Drug | p-hydroxyhippuric acid | 4.31e-06 | 14 | 189 | 4 | CID000151012 | |
| Drug | AC1NSKPI | 7.71e-06 | 57 | 189 | 6 | CID005311482 | |
| Drug | ethylketocyclazocine | 8.55e-06 | 58 | 189 | 6 | CID000135018 | |
| Drug | lead arsenate | 9.43e-06 | 89 | 189 | 7 | CID000024572 | |
| Drug | NSC624987 | 2.99e-05 | 22 | 189 | 4 | CID000001472 | |
| Drug | AC1L25Y6 | 3.60e-05 | 23 | 189 | 4 | CID000015465 | |
| Drug | Palatinose hydrate | 3.60e-05 | 23 | 189 | 4 | CID000093971 | |
| Drug | lanthanum chloride hydrate | 3.60e-05 | 23 | 189 | 4 | CID000165791 | |
| Drug | agelasine B | 3.89e-05 | 46 | 189 | 5 | CID006439899 | |
| Drug | methyl 9-octadecenoate | 4.22e-05 | 112 | 189 | 7 | CID000008202 | |
| Drug | AC1MBZB6 | 4.56e-05 | 9 | 189 | 3 | CID002733620 | |
| Drug | cyhexatin | 5.08e-05 | 25 | 189 | 4 | CID005364545 | |
| Drug | AC1L1G0K | 5.30e-05 | 49 | 189 | 5 | CID000003473 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 2.63e-08 | 6 | 193 | 4 | DOID:0050429 (implicated_via_orthology) | |
| Disease | clopidogrel metabolite measurement | 6.93e-08 | 33 | 193 | 6 | EFO_0007966 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 3.21e-05 | 28 | 193 | 4 | DOID:1094 (implicated_via_orthology) | |
| Disease | muscular atrophy (biomarker_via_orthology) | 3.71e-05 | 29 | 193 | 4 | DOID:767 (biomarker_via_orthology) | |
| Disease | Charlevoix-Saguenay spastic ataxia (implicated_via_orthology) | 4.26e-05 | 2 | 193 | 2 | DOID:0050946 (implicated_via_orthology) | |
| Disease | LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM | 4.26e-05 | 2 | 193 | 2 | 607694 | |
| Disease | Leukoencephalopathy-ataxia-hypodontia-hypomyelination syndrome | 4.26e-05 | 2 | 193 | 2 | cv:C2676243 | |
| Disease | Grand Mal Status Epilepticus | 7.90e-05 | 67 | 193 | 5 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 7.90e-05 | 67 | 193 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 7.90e-05 | 67 | 193 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 7.90e-05 | 67 | 193 | 5 | C0751523 | |
| Disease | Petit mal status | 7.90e-05 | 67 | 193 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 7.90e-05 | 67 | 193 | 5 | C0393734 | |
| Disease | Status Epilepticus | 8.48e-05 | 68 | 193 | 5 | C0038220 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex V Deficiency | 8.87e-05 | 36 | 193 | 4 | C1850600 | |
| Disease | Necrotizing encephalopathy, infantile subacute, of Leigh | 8.87e-05 | 36 | 193 | 4 | C2931891 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex III Deficiency | 8.87e-05 | 36 | 193 | 4 | C1850598 | |
| Disease | Leigh Syndrome Due To Mitochondrial Complex II Deficiency | 8.87e-05 | 36 | 193 | 4 | C1850597 | |
| Disease | Leigh Syndrome due to Mitochondrial Complex IV Deficiency | 8.87e-05 | 36 | 193 | 4 | C1850599 | |
| Disease | LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY | 9.90e-05 | 37 | 193 | 4 | C1838951 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.18e-04 | 15 | 193 | 3 | DOID:2018 (biomarker_via_orthology) | |
| Disease | hypomyelinating leukodystrophy (implicated_via_orthology) | 1.27e-04 | 3 | 193 | 2 | DOID:0060786 (implicated_via_orthology) | |
| Disease | Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism | 1.27e-04 | 3 | 193 | 2 | C2676243 | |
| Disease | POLR3-related leukodystrophy | 1.27e-04 | 3 | 193 | 2 | cv:C5679947 | |
| Disease | platelet-to-lymphocyte ratio | KNTC1 IQGAP2 MEF2C IQGAP1 PTPRJ MED12L AFF1 CCR7 ZNF322 PXT1 | 1.50e-04 | 363 | 193 | 10 | EFO_0008446 |
| Disease | reticulocyte count | USP34 ATR MYO1D IQGAP2 RGS9 KCNU1 PTPRJ SYNE2 NYAP1 MED12 HSP90AB1 ST3GAL4 SLFN12L DPF3 NT5C2 OTUD4 ATP2B1 ATP2B4 | 1.87e-04 | 1045 | 193 | 18 | EFO_0007986 |
| Disease | tyrosine-protein kinase TEC measurement | 2.53e-04 | 4 | 193 | 2 | EFO_0020830 | |
| Disease | Leigh Disease | 2.54e-04 | 47 | 193 | 4 | C0023264 | |
| Disease | seborrheic dermatitis | 2.89e-04 | 20 | 193 | 3 | EFO_1000764 | |
| Disease | alpha-tocopherol measurement | 2.89e-04 | 20 | 193 | 3 | EFO_0007898 | |
| Disease | Woolly hair, congenital | 4.20e-04 | 5 | 193 | 2 | C0345427 | |
| Disease | procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement | 4.20e-04 | 5 | 193 | 2 | EFO_0802912 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.09e-04 | 152 | 193 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Weight Gain | 5.67e-04 | 102 | 193 | 5 | C0043094 | |
| Disease | multiple sclerosis | IL12B MEF2C ASAP1 IQGAP1 TNFSF4 MGAT5 AFF1 CLEC16A EXOC6 MMS22L TRIM42 PXT1 | 5.77e-04 | 594 | 193 | 12 | MONDO_0005301 |
| Disease | Conn Syndrome | 6.27e-04 | 6 | 193 | 2 | C1384514 | |
| Disease | Enterovirus Infections | 6.27e-04 | 6 | 193 | 2 | C0014378 | |
| Disease | macrophage colony-stimulating factor 1 receptor measurement | 6.27e-04 | 6 | 193 | 2 | EFO_0020547 | |
| Disease | Hyperaldosteronism | 6.27e-04 | 6 | 193 | 2 | C0020428 | |
| Disease | testosterone measurement | DRAM1 WDR81 IQGAP1 MGAT5 PTPRJ SYNE2 USP7 AFF1 USH2A MED12 NRDC TASL OPHN1 OPRM1 MSH6 CRTAM ATP1A3 ATP2B2 ATP2B4 | 7.41e-04 | 1275 | 193 | 19 | EFO_0004908 |
| Disease | systemic lupus erythematosus | IL12B CEL DRAM1 TNFSF4 MGAT5 AFF1 CLEC16A LMNTD1 ANXA6 TASL TRMT44 DPF3 PXT1 NT5C2 | 8.30e-04 | 799 | 193 | 14 | MONDO_0007915 |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 8.75e-04 | 7 | 193 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | Wooly hair | 8.75e-04 | 7 | 193 | 2 | C0343073 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 8.88e-04 | 29 | 193 | 3 | C0496920 | |
| Disease | Ovarian Carcinoma | 9.82e-04 | 30 | 193 | 3 | C0029925 | |
| Disease | progressive supranuclear palsy | 1.08e-03 | 31 | 193 | 3 | MONDO_0019037 | |
| Disease | Nonorganic psychosis | 1.10e-03 | 69 | 193 | 4 | C0349204 | |
| Disease | response to atorvastatin, Myalgia | 1.16e-03 | 8 | 193 | 2 | EFO_0010124, HP_0003326 | |
| Disease | allergic disease, age at onset | 1.22e-03 | 71 | 193 | 4 | EFO_0004847, MONDO_0005271 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.42e-03 | 34 | 193 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | scavenger receptor cysteine-rich type 1 protein m130 measurement | 1.49e-03 | 9 | 193 | 2 | EFO_0020717 | |
| Disease | Heroin Dependence | 1.49e-03 | 9 | 193 | 2 | C0019337 | |
| Disease | Heroin Smoking | 1.49e-03 | 9 | 193 | 2 | C4505390 | |
| Disease | heroin abuse | 1.49e-03 | 9 | 193 | 2 | C0600241 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.50e-03 | 75 | 193 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | lymphocyte count | CEL MYO1D IQGAP2 IQGAP1 PTPRJ MED12L USP7 AFF1 HFM1 CCR7 CLEC16A IPPK EXOC6 MMS22L ANXA6 ST3GAL4 SLFN12L SBNO1 LPAR6 ATP2B4 | 1.54e-03 | 1464 | 193 | 20 | EFO_0004587 |
| Disease | Hypertensive disease | 1.62e-03 | 190 | 193 | 6 | C0020538 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.68e-03 | 36 | 193 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement | 1.68e-03 | 260 | 193 | 7 | EFO_0008317 | |
| Disease | diabetic retinopathy | 2.05e-03 | 136 | 193 | 5 | EFO_0003770 | |
| Disease | myositis | 2.12e-03 | 39 | 193 | 3 | EFO_0000783 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 2.12e-03 | 39 | 193 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | pancreatitis (biomarker_via_orthology) | 2.12e-03 | 39 | 193 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | interleukin-6 measurement, response to stimulus | 2.25e-03 | 11 | 193 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Dystonia | 2.48e-03 | 86 | 193 | 4 | C0013421 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.62e-03 | 42 | 193 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Methionine sulfoxide measurement | 2.69e-03 | 12 | 193 | 2 | EFO_0021650 | |
| Disease | nervous system disease (implicated_via_orthology) | 2.69e-03 | 12 | 193 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | polycystic ovary syndrome (is_marker_for) | 2.69e-03 | 12 | 193 | 2 | DOID:11612 (is_marker_for) | |
| Disease | anti-Epstein Barr virus antibody measurement | 2.69e-03 | 12 | 193 | 2 | EFO_0009273 | |
| Disease | disks large homolog 3 measurement | 2.69e-03 | 12 | 193 | 2 | EFO_0802472 | |
| Disease | obesity (implicated_via_orthology) | 3.00e-03 | 215 | 193 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | phosphocreatine measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0010521 | |
| Disease | glutaroyl carnitine measurement | 3.17e-03 | 13 | 193 | 2 | EFO_0021005 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.36e-03 | 220 | 193 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | carbohydrate measurement | 3.40e-03 | 46 | 193 | 3 | EFO_0004998 | |
| Disease | orotic acid measurement | 3.68e-03 | 14 | 193 | 2 | EFO_0010516 | |
| Disease | hearing impairment | 3.97e-03 | 98 | 193 | 4 | C1384666 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.08e-03 | 229 | 193 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | myocardial infarction (is_implicated_in) | 4.12e-03 | 99 | 193 | 4 | DOID:5844 (is_implicated_in) | |
| Disease | hypertension | 4.23e-03 | 307 | 193 | 7 | EFO_0000537 | |
| Disease | status epilepticus (biomarker_via_orthology) | 4.27e-03 | 100 | 193 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 4.31e-03 | 50 | 193 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 4.34e-03 | 162 | 193 | 5 | EFO_0004612, EFO_0007878 | |
| Disease | Psychotic Disorders | 4.42e-03 | 101 | 193 | 4 | C0033975 | |
| Disease | epilepsy (implicated_via_orthology) | 4.46e-03 | 163 | 193 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 4.81e-03 | 16 | 193 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | cutaneous psoriasis measurement, psoriasis | 4.81e-03 | 16 | 193 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | IGF-1 measurement | 5.03e-03 | 488 | 193 | 9 | EFO_0004627 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 5.06e-03 | 168 | 193 | 5 | EFO_0004329, EFO_0004612 | |
| Disease | abdominal adipose tissue measurement | 5.08e-03 | 53 | 193 | 3 | EFO_0803316 | |
| Disease | complement factor H-related protein 3 measurement | 5.19e-03 | 169 | 193 | 5 | EFO_0600056 | |
| Disease | response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant | 5.43e-03 | 17 | 193 | 2 | EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276 | |
| Disease | Psychoses, Substance-Induced | 5.43e-03 | 17 | 193 | 2 | C0033941 | |
| Disease | MHPG measurement, 5-HIAA measurement | 5.43e-03 | 17 | 193 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | PR interval | 5.51e-03 | 495 | 193 | 9 | EFO_0004462 | |
| Disease | physical activity measurement | 5.65e-03 | 245 | 193 | 6 | EFO_0008002 | |
| Disease | noggin measurement | 6.08e-03 | 18 | 193 | 2 | EFO_0021995 | |
| Disease | Malignant neoplasm of endometrium | 6.08e-03 | 18 | 193 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 6.08e-03 | 18 | 193 | 2 | C0346191 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASVGMYLISKYIRKN | 341 | P08243 | |
| DIVKYNTYMRNTSKQ | 256 | O15372 | |
| IRKYYMSLKSEVATI | 1196 | P29374 | |
| TTYANSSLIKYMEKH | 286 | Q9BWU1 | |
| QMYEIILFTASKKVY | 341 | Q05D32 | |
| KMVIYDLHESTYKQE | 2296 | Q68DQ2 | |
| ASSLAKKCMAVYQTY | 271 | Q9UKF6 | |
| FLATNSDYKYTDKIM | 246 | P49902 | |
| AYHITVYMKDVKVSL | 161 | Q15848 | |
| YYSLVMSQDIKKADE | 616 | Q2M3G0 | |
| IVIYFYMKLKTVASV | 51 | P30556 | |
| NATYIAKTTVMKYLE | 1406 | Q8WXG9 | |
| KSSSSDEEYIYMNKV | 46 | Q8N4X5 | |
| LTYIYFKRLKTMTDT | 81 | P32248 | |
| ALVYQKYVEMTTLLD | 666 | Q96DT5 | |
| SYVLEPMKSATNRYK | 151 | O43184 | |
| KIYIVMNYVEHDLKS | 511 | P21127 | |
| LYYLSTTVKEMSKKA | 996 | P11532 | |
| KREMVSQYLYTSKAG | 121 | O60610 | |
| YTTENSGYLEITKKM | 511 | P19835 | |
| MITELILASKSYYDI | 16 | Q9UBS3 | |
| LVAYNKQDMYLSSKE | 1116 | Q9Y485 | |
| RAQKYTYLKMDGTTT | 876 | Q03468 | |
| ALYKVYTFNSVRKSM | 571 | P20020 | |
| LYKVYTFNSVRKSMS | 596 | Q01814 | |
| YKVYTFNSVRKSMST | 571 | Q16720 | |
| KLYKVYTFNSVRKSM | 561 | P23634 | |
| NYILTLMSIVATIYK | 281 | P59510 | |
| EIFRTKYEKSLYSMI | 291 | P08133 | |
| KYEKSLYSMIKNDTS | 296 | P08133 | |
| NKSTKFMDSVIFTLY | 996 | P46940 | |
| MTALRYQKKFTEYSA | 211 | Q9UPQ7 | |
| IVYPIKYKESSAMCQ | 151 | Q01804 | |
| KYKESSAMCQSLLYE | 156 | Q01804 | |
| TVVAVKKEIMYYQQA | 221 | O75916 | |
| YYSKTVRAKDNAVMS | 461 | Q9H8X2 | |
| KYYCQYEKETKTLTM | 286 | O60890 | |
| TMKTYVEKVANGQYS | 386 | Q15397 | |
| YTYESKMAFLTRVAK | 1551 | Q92621 | |
| NVNSKFYSTTALKYM | 566 | Q9UPP5 | |
| DKEYRNAVSKYTMAL | 56 | Q9UJX3 | |
| SAQLLYKMIKSKTEY | 206 | Q9P2R3 | |
| LGAATMYTRYKIVQK | 66 | Q8N682 | |
| FYGSILSMYVQLKKS | 251 | Q8NGY5 | |
| MKETQKSIYYITGES | 476 | P08238 | |
| KVDLIYQNTTAMTIY | 1306 | Q12913 | |
| VRYTKMKTATNIYIF | 96 | P35372 | |
| KMTCAYYSAISEAKI | 161 | Q86YW9 | |
| RSYYETSKMKVLKFA | 446 | Q9UNF1 | |
| NKKIYLDIIHTYMEV | 461 | Q09328 | |
| LQFTLNMTEAVKTYK | 296 | Q92784 | |
| MVTKSLEYLGEVLKY | 911 | Q6ZRQ5 | |
| YSMSSTYIDKLKTVN | 1161 | Q03001 | |
| EEYVSRMKEIQKSIY | 246 | Q58FF8 | |
| VSHMKETQKSTYYIT | 346 | Q58FF7 | |
| FSYYQEAKSSKIMES | 146 | P05023 | |
| KLEYKYSKLVMNATL | 936 | Q6UXG2 | |
| SGSVMYIEEKTKTKY | 271 | Q9UHG3 | |
| SVTMSYLEIYQEKVL | 171 | Q14807 | |
| YKDDVLFYNISSMKS | 76 | P16284 | |
| KVTVLEMSEYLNKYE | 686 | Q32MH5 | |
| VIKGKVLYTYMASED | 1386 | Q6ZNL6 | |
| LMYSLVYNLTKELKS | 161 | Q9HBA9 | |
| KIVYSMYSRKAAEEV | 586 | Q2PZI1 | |
| SDFAQLQKYMEYSTK | 11 | P23743 | |
| LQKYMEYSTKKVSDV | 16 | P23743 | |
| SRKNAKVITDYYVDM | 556 | Q96JB8 | |
| YISMIVKKRYSTTRS | 2036 | Q9HD67 | |
| QYETLSEEMTYLKKN | 206 | Q7Z3Z0 | |
| ITYETTQEMLNYAKT | 481 | P50748 | |
| EKEEAYNSLMKSYVS | 1316 | P42704 | |
| YNSLMKSYVSEKDVT | 1321 | P42704 | |
| NYTQKTLKYFSMILE | 121 | Q8N9Z9 | |
| KMTCAYYAAISETKV | 161 | Q93074 | |
| QYASTDMDKVLLKYT | 56 | Q06413 | |
| YISQFIIMYSLDGKK | 2116 | P00451 | |
| MVELFANKRKYTSSY | 311 | A8MYU2 | |
| YYFTSDTIQNSIKMK | 291 | P43657 | |
| LLYQSFVKDYMISIT | 896 | Q6UVM3 | |
| QYASTDMDKVLLKYT | 56 | Q02078 | |
| EAYKTLSSLYSEMQK | 226 | Q86WC4 | |
| FVTFQEKSMATYILK | 351 | O94886 | |
| RAIMYEETTYSKKKI | 841 | P52701 | |
| MVDAVHKLKYENYTS | 211 | P29460 | |
| AMTTRKKETYQSVYN | 391 | Q9Y3T9 | |
| VTLTEMNYSKYGAKE | 426 | O94880 | |
| LEYKYSKLVMTTNSK | 956 | A8MWY0 | |
| KEQMSAKRYYSALKT | 146 | Q8TAG9 | |
| AKRYYSALKTMEQLE | 151 | Q8TAG9 | |
| EYAANLKSMVQYLKS | 106 | Q2TAA2 | |
| KTTKFMEAVIFSLYN | 981 | Q86VI3 | |
| MQSAKYFNYTVKVLG | 56 | O00469 | |
| LETMSYIKTINLKDY | 631 | Q8N475 | |
| MVDTYIKLYTSKSEL | 736 | O43422 | |
| QEINTKSAFLKMIYS | 841 | Q5T6X5 | |
| LTLNYKIASVIQMYS | 511 | A2PYH4 | |
| MLVNFLVTKKTISYY | 81 | Q8NGG1 | |
| MAEYSYVKSTKLVLK | 1 | Q14331 | |
| KVVASKAQMMTYYTV | 226 | P0CF75 | |
| VVKIYDALIYMQVNS | 566 | Q13535 | |
| NEYTMYRISSISKIF | 71 | A8MY62 | |
| LYYDKEQTVSMKDNV | 256 | P22748 | |
| RCMNYITKLYSEAKT | 356 | O95727 | |
| ETVMTTLYTAKKYAV | 146 | Q9H0C5 | |
| YIGTVQYKIKMFNSV | 221 | Q8N3K9 | |
| YMLIVKVSDGKFYST | 1951 | Q8TDW7 | |
| MTVRKEYITAKYVDH | 536 | Q9ULH1 | |
| SKTYKETTLVVYIMT | 371 | Q9UPI3 | |
| TQELMIDVTKSYYQK | 161 | Q9BTE1 | |
| KEYSDDKVQLAMQTY | 76 | Q8WYH8 | |
| IAIKVTEYLYANKMA | 526 | P23368 | |
| FSYYQEAKSSKIMES | 136 | P13637 | |
| SLVKVENNMVSLYKY | 341 | Q99518 | |
| KEAAYKVMSENYLQV | 451 | Q5VTJ3 | |
| LTYVEMQLLYTKDKS | 126 | Q8NCS7 | |
| VTFKTLDDMISYYKQ | 451 | Q6PII3 | |
| YYETVSDVLNSVKKM | 646 | Q14746 | |
| KESYSMYIYKVLKQV | 31 | A0A2R8Y619 | |
| AKKYMKSTYEQVDLI | 386 | Q9NR30 | |
| LYNASKARSKTYINM | 526 | P20807 | |
| VSSHKCKVMYYTEVI | 661 | Q92503 | |
| KLKNLTGYTAYMVSV | 1686 | Q58EX2 | |
| RSMYITYSTKSQKDV | 456 | Q9BZV2 | |
| FTQSVKSMYLKYLKI | 1686 | Q9NZJ4 | |
| EEVLLSQSYVKMYNK | 546 | A3KN83 | |
| MYCRKYKATLVIQTE | 3106 | Q6ZTR5 | |
| MNLDTASEKQYTIYI | 281 | Q99496 | |
| QYASTDMDKVLLKYT | 56 | Q14814 | |
| KAVSYTMVYSAVKVT | 456 | Q6ZVC0 | |
| TMTKYKGQLYLLVTD | 451 | Q8NBR6 | |
| QKIGSNYKAYMRTSI | 296 | O14994 | |
| KLTISEKETMFYYRT | 176 | O75445 | |
| YVILRYAKMKTATNI | 81 | P30872 | |
| QKEIEKYVYVTTMKV | 406 | Q8IWZ5 | |
| LISIMKYSKAYQELK | 296 | Q8IYL2 | |
| KASRVKPVEYSQMYS | 176 | Q9NX07 | |
| EKSIMTYVAQFLQYS | 271 | Q8WXH0 | |
| DVCMYRKNIYNVKST | 566 | Q8WXH0 | |
| YKERLFVLTKSMLTY | 26 | P42680 | |
| CKSLSSEMYVKSYTI | 2141 | P12259 | |
| ETDTETIAKLVKYMY | 146 | Q06210 | |
| TIAKLVKYMYDNRES | 151 | Q06210 | |
| KEMVDYSNTYKTVKT | 501 | Q969F9 | |
| MVSEKKIYDVEQTRY | 86 | Q13576 | |
| MKSTRYLQTQGSVYK | 336 | P25103 | |
| SKSSMYYVLQFLKED | 1181 | O14802 | |
| VILRYAKMKTATNIY | 71 | P31391 | |
| QTIHYYEQITLKSMA | 291 | Q11206 | |
| YAASKKTIYTYIMAS | 271 | Q9UIB8 | |
| AKVYMQVYSSKTNFT | 116 | Q8N5S1 | |
| AVMKVYSKEDYSVVN | 1221 | O75592 | |
| SVAASKKKVYMLYNL | 141 | Q9H1D9 | |
| IKTMLEYADKVFTYI | 1236 | Q9NY46 | |
| INKISMQAVLDYLYT | 531 | O94844 | |
| IASLTYIIKMVEQQY | 306 | G3V0H7 | |
| VKLYSLFLKYDATMI | 241 | Q9P2R7 | |
| TLSMESAVNTYKYAK | 946 | Q8N961 | |
| NVVSTYISKMKVIYP | 526 | P21589 | |
| YSVYSETVDLIKFIM | 1016 | P51825 | |
| EEIMAYYISFLKTLS | 136 | Q2KHT3 | |
| NKKAITYTYDLMANL | 131 | Q6DKK2 | |
| YLLTGSYDMKIKVTD | 856 | O94967 | |
| NYMYTAKISVKKEDV | 91 | O43829 | |
| STIKKRLQEDYSMYS | 946 | O15164 | |
| DDLVTKMKQFYSYTL | 511 | Q86Y38 | |
| NSLMVASLTYKDKVY | 136 | P23510 | |
| YTKKVCVMTKIFYLS | 506 | Q6IEE8 | |
| KILSMIYKLVQSNTY | 116 | Q9Y5K1 | |
| SKYQNYIMEGVKATI | 111 | Q9Y508 | |
| QKVVELYKQYIMDTV | 216 | Q9HAI6 | |
| ETLAYFIYMVKSNKS | 156 | Q9HAJ7 | |
| TNFDVYSQKSAMYEK | 501 | O43280 | |
| KMRTQTEELHYKYTV | 341 | Q6U7Q0 | |
| SRTNFTSKYNMKVLY | 76 | P04216 | |
| TSKYNMKVLYLSAFT | 81 | P04216 | |
| FTMITEQLKKTYFNI | 791 | O43847 | |
| QCGITYKMEKVYSTL | 281 | Q9NVG8 | |
| ITYKGATDSYIEKVM | 856 | Q9NW08 | |
| ETLQKYLKVVMALTY | 426 | Q8IV63 | |
| RYQMESFSKYSSVQK | 21 | Q96NL6 | |
| AESLFKESYYQLMKT | 181 | P19623 | |
| KFYEMYLLINKAEST | 576 | Q8IZJ1 | |
| TRMYEYKKIAAQKTI | 171 | O95347 | |
| YFKQMEVKESYITLA | 646 | O60290 | |
| LATEYLQLMVYVTKT | 231 | O14788 | |
| VTSTLYNKIYQLTMD | 421 | Q9BY10 | |
| LMYSITKGYIKSQED | 741 | Q5TAH2 | |
| IADKPMTQYQDTSKY | 216 | O75940 | |
| SVESIKNGLVYMKYD | 476 | P22735 | |
| SMCQKTAIIQYEVKY | 191 | Q5SVZ6 | |
| SSTKVKDEYMVAEYA | 351 | Q9UQR1 | |
| YCLISKTEKLMFSTY | 2761 | Q70CQ2 | |
| YTADMQKTISAYIKM | 531 | Q2TBF2 | |
| SQDKSAVIAKNMYYL | 716 | Q9NYU1 | |
| TNAYMLVYIRESKLS | 511 | Q93009 | |
| LKYSFQKAYMTQLVS | 31 | Q8NFP0 | |
| YSMIVAYSLKQKLVN | 466 | Q08AF3 | |
| QISYVYKEAMVVSSF | 126 | Q5VZQ5 | |
| LQKVFTLEMAYTIYV | 1476 | Q562E7 | |
| AVIVYQLYSLMSSEK | 431 | Q9GZU3 | |
| SQMIISYEKIPSYRK | 176 | Q8N7M2 | |
| AGKTEASKYIMQYIA | 106 | O94832 | |
| KTVAAKYIMGYISKV | 116 | O00160 | |
| FSVKVEQAKYVSMTI | 1391 | P54296 |